Obagi Medical Products

Obagi Medical Products is owned by China Regenerative Medicine.

China Regenerative Medicine is a company listed under the stock ticker 8158 (HK).

China Regenerative Medicine has a direct presence in 2 countries.

They are in:

• Medical Equipment50%
• Pharmaceuticals50%

View the org chart displaying its 4 main executives

Most searched biographies at Obagi Medical Products

• Christopher Fletcher, Vice President, International Sales
• Amy Campbell, Vice President, Global Marketing
• David Bell, Vice President, Sales

Create your alert
to follow the executive moves at Obagi Medical Products.

China Regenerative Medicine has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Obagi Medical Products

Social media about Obagi Medical Products

• Obagi Medical Products on Wikipedia, Google News & Yahoo Finance
• Obagi Medical Products on LinkedIn, Twitter & YouTube

Contact by email its executives including Amy Campbell

Call Obagi Medical Products at +1 562...

View the org chart

Register to receive your alert

Report an error